Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Latest filing published 09 Dec 2025 for Ovid Therapeutics Inc.. Read the official filing
Filing timeline
BuySaleTakeda Pharmaceutical Co Ltd
Insider track record
Disclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Takeda Pharmaceutical Co Ltd: trading record in brief
Filings by Takeda Pharmaceutical Co Ltd span 6 companies, the busiest being Phathom Pharmaceuticals, Inc., Day One Biopharmaceuticals, Inc. and HilleVax, Inc. Over a trading history stretching from 3 May 2021 to 8 December 2025, the count stands at 31 filings.
On the market, this insider has only sold: 22 sales, €33.1M in total. The rest of the record consists of 3 share grants.
The newest entry dates from 9 December 2025: a transaction, in Ovid Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Takeda Pharmaceutical Co Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
1,250,000 shares0Common StockSEC:0001395064-25-000172:0
6,724,000 shares@ US$1.95100.0% of flowCommon StockSEC:0001395064-25-000140:0
3,703,703 shares@ US$8.1081.7% of flowCommon StockSEC:0001395064-24-000008:0
5,883,500 shares0Common StockSEC:0001395064-22-000146:0
5,750,000 shares0Common StockSEC:0001395064-22-000121:0
7,359,304 shares0Common StockSEC:0001395064-22-000040:0
128,745 shares@ US$18.430.22% mcap45.6% of flowCommon StockSEC:0001395064-21-000248:0
12,517 shares@ US$18.470.021% mcap4.4% of flowCommon StockSEC:0001395064-21-000246:0
57,224 shares0Common StockSEC:0001395064-21-000238:0
228,696 shares0Common StockSEC:0001395064-21-000231:0
1,475,121 sharesCommon StockSEC:0001395064-21-000216:0
1,615,427 sharesCommon StockSEC:0001395064-21-000203:0
2,609 shares@ US$35.050.3% of flowCommon StockSEC:0001395064-21-000153:0
8,226 shares@ US$35.160.8% of flowCommon StockSEC:0001395064-21-000148:0
22,881 shares@ US$35.462.2% of flowCommon StockSEC:0001395064-21-000142:0
200 shares@ US$35.000.0% of flowCommon StockSEC:0001395064-21-000125:0
9,294 shares@ US$35.310.9% of flowCommon StockSEC:0001395064-21-000121:0
3,305 shares@ US$35.080.3% of flowCommon StockSEC:0001395064-21-000119:0
2,826 shares@ US$35.060.3% of flowCommon StockSEC:0001395064-21-000113:0
1,191 shares@ US$35.280.1% of flowCommon StockSEC:0001395064-21-000111:0
2,264 shares@ US$35.050.2% of flowCommon StockSEC:0001395064-21-000109:0
4,300 shares@ US$35.180.4% of flowCommon StockSEC:0001395064-21-000107:0
4,133 shares@ US$35.370.4% of flowCommon StockSEC:0001395064-21-000105:0
7,469 shares@ US$36.450.7% of flowCommon StockSEC:0001395064-21-000103:0
8,911 shares@ US$35.580.8% of flowCommon StockSEC:0001395064-21-000089:0
25 of 31 declarations
